Results 281 to 290 of about 472,711 (314)

Self-efficacy and social support for psychological well-being of family caregivers of care recipients with dementia with Lewy bodies, Parkinson’s disease dementia, or Alzheimer’s disease

Social Work in Mental Health, 2018
The study identified factors associated with depressive symptoms in family caregivers of persons with dementia with Lewy bodies, Alzheimer’s disease, or Parkinson’s disease dementia. An Internet-based survey generated 606 response sets.
Juyoung Park, M. Tolea, Victoria Arcay, Yve Lopes, J. Galvin   +4 more
semanticscholar   +1 more source

Clinical diagnostic criteria for dementia associated with Parkinson's disease

Movement Disorders, 2007
M. Emre, D. Aarsland, Richard G. Brown, D. Burn, C. Duyckaerts, Y. Mizuno, G. Broe, J. Cummings, D. Dickson, S. Gauthier, J. Goldman, C. Goetz, A. Korczyn, A. Lees, R. Levy, I. Litvan, I. McKeith, W. Olanow, W. Poewe, N. Quinn, C. Sampaio, E. Tolosa, B. Dubois   +22 more
semanticscholar   +1 more source

Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies

Journal of neural transmission, 2018
K. Jellinger
semanticscholar   +1 more source

Lipid metabolic dysregulation is involved in Parkinson’s disease dementia

Metabolic brain disease, 2021
Mei-Xue Dong, Youdong Wei, Ling Hu
semanticscholar   +1 more source

Cancer care for people with dementia: Literature overview and recommendations for practice and research

Ca-A Cancer Journal for Clinicians, 2023
Laura Ashley
exaly  

Amyloid load in Parkinson’s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography

Journal of Neurology Neurosurgery & Psychiatry, 2008
P. Edison, C. Rowe, J. Rinne, S. Ng, Imtiaz Ahmed, N. Kemppainen, V. Villemagne, G. O'Keefe, K. Någren, K. R. Chaudhury, C. Masters, D. Brooks   +11 more
semanticscholar   +1 more source

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

Lancet Public Health, The, 2022
Fares Alahdab, Iman Ansari, Jalal arabloo   +2 more
exaly  

Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis

Journal of Neurology Neurosurgery & Psychiatry, 2014
Hui-Fu Wang, Jin-Tai Yu, Shaowen Tang, Teng Jiang, Chen-Chen Tan, Xiang-Fei Meng, Chong Wang, M. Tan, L. Tan   +8 more
semanticscholar   +1 more source

Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia

Nature Medicine, 2020
Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist   +2 more
exaly  

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial

Lancet Neurology, 2009
D. Aarsland, C. Ballard, Z. Walker, F. Bostrom, G. Alves, K. Kossakowski, I. Leroi, F. Pozo-Rodríguez, L. Minthon, E. Londos   +9 more
semanticscholar   +1 more source